文献速递产科母胎医学

孕妇重症或危重症COVID-19复合发病率高于非孕对照

Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
PubMed 文献 · Am J Obstet Gynecol · 2020-11-20

这项多中心回顾性病例对照研究纳入2020年3月至5月纽约和费城5家学术中心的育龄女性,比较因重症或危重症COVID-19住院的孕妇与非孕对照的结局。孕妇复合发病率(34.2% vs 14.9%,P=.03)、ICU入住率(39.5% vs 17.0%,P<.01)均显著更高,提示妊娠可能与更差结局相关。

要点

  • 孕妇重症/危重症COVID-19复合发病率为34.2%,高于非孕对照的14.9%。
  • 孕妇ICU入住率为39.5%,高于非孕对照的17.0%。
  • 调整后孕妇复合发病风险仍升高(aOR 4.6,95%CI 1.2-18.2)。

核心结论

  • 孕妇重症或危重症COVID-19的复合发病率、插管/机械通气及ICU入住风险高于非孕对照。
  • 尽管非孕对照糖尿病和高血压患病率更高,孕妇仍表现出更高的复合发病风险。
  • 妊娠可能与重症或危重症COVID-19的更差结局相关。

研究设计与样本

  • 多中心、回顾性、病例对照研究,纳入纽约4家和费城1家学术医学中心2020年3月12日至5月5日收治的实验室确诊SARS-CoV-2感染女性。
  • 病例为因重症或危重症COVID-19而非产科指征收治的孕妇(n=38,其中重症29例[76.3%]、危重症9例[23.7%])。
  • 对照为因重症或危重症COVID-19收治的育龄非孕女性。
  • 主要结局为复合发病率:死亡、需插管、体外膜氧合、无创正压通气或需高流量鼻导管吸氧。

主要发现

  • 孕妇复合发病率34.2%,非孕对照14.9%(P=.03;调整OR 4.6,95%CI 1.2-18.2)。
  • 孕妇ICU入住率39.5%,非孕对照17.0%(P<.01;调整OR 5.2,95%CI 1.5-17.5)。
  • 孕妇分娩者中72.7%为剖宫产分娩;重症者平均分娩孕周33.8±5.5周,危重症者35±3.5周。
  • 非孕对照平均年龄和BMI显著更高,且糖尿病、高血压和冠心病等基础合并症更常见。

关键数值与推荐

  • 主要结局复合发病率包括死亡、需插管、体外膜氧合、无创正压通气或需高流量鼻导管吸氧。
  • 重症COVID-19孕妇中76.3%(29/38)符合重症标准,23.7%(9/38)符合危重症标准。
  • 孕妇复合发病率34.2% vs 14.9%(P=.03;aOR 4.6,95%CI 1.2-18.2)。
  • 孕妇ICU入住率39.5% vs 17.0%(P<.01;aOR 5.2,95%CI 1.5-17.5)。

临床怎么用

  • 对重症或危重症COVID-19孕妇应提高警惕,加强监护并及早评估ICU转入需求。
  • 妊娠不应被视为重症COVID-19的保护因素,临床决策需考虑妊娠相关风险。
  • 孕妇重症或危重症COVID-19分娩多经剖宫产,且分娩孕周偏早,需多学科协作管理。

局限性

  • 回顾性病例对照设计,样本量较小(孕妇38例),可能存在选择偏倚和残余混杂。
  • 非孕对照年龄和BMI更高且合并症更多,可能影响组间比较。
  • 研究仅纳入2020年3月至5月纽约和费城5家学术中心,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In March 2020, as community spread of severe acute respiratory syndrome coronavirus 2 became increasingly prevalent, pregnant women seemed to be equally susceptible to developing coronavirus disease 2019. Although the disease course usually appears mild, severe and critical cases of coronavirus disease 2019 seem to lead to substantial morbidity, including intensive care unit admission with prolonged hospital stay, intubation, mechanical ventilation, and even death. Although there are recent reports regarding the impact of coronavirus disease 2019 on pregnancy, there is a lack of information regarding the severity of coronavirus disease 2019 in pregnant vs nonpregnant women. OBJECTIVE: We aimed to describe the outcomes of severe and critical cases of coronavirus disease 2019 in pregnant vs nonpregnant, reproductive-aged women. STUDY DESIGN: This is a multicenter, retrospective, case-control study of women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection hospitalized with severe or critical coronavirus disease 2019 in 4 academic medical centers in New York City and 1 in Philadelphia between March 12, 2020, and May 5, 2020. The cases consisted of pregnant women admitted specifically for severe or critical coronavirus disease 2019 and not for obstetrical indications. The controls consisted of reproductive-aged, nonpregnant women admitted for severe or critical coronavirus disease 2019. The primary outcome was a composite morbidity that includes the following: death, a need for intubation, extracorporeal membrane oxygenation, noninvasive positive pressure ventilation, or a need for high-flow nasal cannula O2 supplementation. The secondary outcomes included intensive care unit admission, length of stay, a need for discharge to long-term acute care facilities, and discharge with a home O2 requirement. RESULTS: A total of 38 pregnant women with severe acute respiratory syndrome coronavirus 2 polymerase chain reaction-confirmed infections were admitted to 5 institutions specifically for coronavirus disease 2019, 29 (76.3%) meeting the criteria for severe disease status and 9 (23.7%) meeting the criteria for critical disease status. The mean age and body mass index were markedly higher in the nonpregnant control group. The nonpregnant cohort also had an increased frequency of preexisting medical comorbidities, including diabetes, hypertension, and coronary artery disease. The pregnant women were more likely to experience the primary outcome when compared with the nonpregnant control group (34.2% vs 14.9%; P=.03; adjusted odds ratio, 4.6; 95% confidence interval, 1.2-18.2). The pregnant patients experienced higher rates of intensive care unit admission (39.5% vs 17.0%; P<.01; adjusted odds ratio, 5.2; 95% confidence interval, 1.5-17.5). Among the pregnant women who underwent delivery, 72.7% occurred through cesarean delivery and the mean gestational age at delivery was 33.8±5.5 weeks in patients with severe disease status and 35±3.5 weeks in patients with critical coronavirus disease 2019 status. CONCLUSION: Pregnant women with severe and critical coronavirus disease 2019 are at an increased risk for certain morbidities when compared with nonpregnant controls. Despite the higher comorbidities of diabetes and hypertension in the nonpregnant controls, the pregnant cases were at an increased risk for composite morbidity, intubation, mechanical ventilation, and intensive care unit admission. These findings suggest that pregnancy may be associated with a worse outcome in women with severe and critical cases of coronavirus disease 2019. Our study suggests that similar to other viral infections such as severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, pregnant women may be at risk for greater morbidity and disease severity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol. 2020. PMID: 33221292. doi:10.1016/j.ajog.2020.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。